Search alternatives:
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
de decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a de » _ de (Expand Search), a d (Expand Search), i de (Expand Search)
Showing 561 - 580 results of 106,535 for search '(( 5 ((((we decrease) OR (a decrease))) OR (nn decrease)) ) OR ( a de decrease ))', query time: 1.54s Refine Results
  1. 561
    Pravastatin enhances cell death and reduces G1 accumulation of NSPCs.

    Pravastatin enhances cell death and reduces G1 accumulation of NSPCs. by Ross A. Carson (5184512)

    Published 2018
    Save to List
    Saved in:
  2. 562
    Statins differentially alter NSPC fate through a non-CBP dependent mechanism.

    Statins differentially alter NSPC fate through a non-CBP dependent mechanism. by Ross A. Carson (5184512)

    Published 2018
    Save to List
    Saved in:
  3. 563
    Statins alter mRNA expression in differentiating NSPCs through a non-CBP dependent mechanism.

    Statins alter mRNA expression in differentiating NSPCs through a non-CBP dependent mechanism. by Ross A. Carson (5184512)

    Published 2018
    Save to List
    Saved in:
  4. 564
    Increased AQP2 expression by a vasopressin analogue is decreased by NOX4 depletion in mpkCCD<sub>cl4</sub> cells.

    Increased AQP2 expression by a vasopressin analogue is decreased by NOX4 depletion in mpkCCD<sub>cl4</sub> cells. by Eric Féraille (513934)

    Published 2014
    Save to List
    Saved in:
  5. 565
    Pravastatin induces CBP gene expression in NSPCs.

    Pravastatin induces CBP gene expression in NSPCs. by Ross A. Carson (5184512)

    Published 2018
    Save to List
    Saved in:
  6. 566
    FPP prevents pravastatin dependent SREBP2 activation and induction of cell death.

    FPP prevents pravastatin dependent SREBP2 activation and induction of cell death. by Ross A. Carson (5184512)

    Published 2018
    Save to List
    Saved in:
  7. 567
    NR4A1 expression does not decrease after inhibition of p38, JNK and Src pathways.

    NR4A1 expression does not decrease after inhibition of p38, JNK and Src pathways. by Glenda Eger (636934)

    Published 2014
    Save to List
    Saved in:
  8. 568
    Rac and PKB activities are required for a late phase of cerebellar LTP.

    Rac and PKB activities are required for a late phase of cerebellar LTP. by Claire Jackson (362873)

    Published 2010
    “…<p><b>A</b>) Addition of the Rac inhibitor EHT1864 (50 µM; n = 7) to pipette solution decreases LTP duration. …”
    Save to List
    Saved in:
  9. 569
    Pravastatin activates SREBP2 in NSPCs.

    Pravastatin activates SREBP2 in NSPCs. by Ross A. Carson (5184512)

    Published 2018
    Save to List
    Saved in:
  10. 570
    HPLC-MS tentative identification of phenolic metabolites from the defatted extract (DE) of <i>S. malaccense</i> (SM) and <i>S. samarangense</i> (SS) leaves.

    HPLC-MS tentative identification of phenolic metabolites from the defatted extract (DE) of <i>S. malaccense</i> (SM) and <i>S. samarangense</i> (SS) leaves. by Fatma A. Moharram (9276104)

    Published 2025
    Save to List
    Saved in:
  11. 571
    Estimated total phenolic content (TPC), and total flavonoid content (TFC) in the defatted extract (DE) of <i>S. malaccense</i> and <i>S. samarangense</i> leaves.

    Estimated total phenolic content (TPC), and total flavonoid content (TFC) in the defatted extract (DE) of <i>S. malaccense</i> and <i>S. samarangense</i> leaves. by Fatma A. Moharram (9276104)

    Published 2025
    Save to List
    Saved in:
  12. 572
    A possible explanation for a nonlinear decline in populations could be a decrease in active AMP concentration over time due to degradation.

    A possible explanation for a nonlinear decline in populations could be a decrease in active AMP concentration over time due to degradation. by Alexandro Rodríguez-Rojas (326213)

    Published 2021
    Save to List
    Saved in:
  13. 573
    Table5_Mitochondrial DNA mutations can influence the post-implantation development of human mosaic embryos.DOCX

    Table5_Mitochondrial DNA mutations can influence the post-implantation development of human mosaic embryos.DOCX by Akifumi Ijuin (16817115)

    Published 2023
    Save to List
    Saved in:
  14. 574
    Induction therapy of rATG in simultaneous kidney/pancreas transplantation results in a significant decrease of NK cells.

    Induction therapy of rATG in simultaneous kidney/pancreas transplantation results in a significant decrease of NK cells. by Diana Stauch (266579)

    Published 2009
    Save to List
    Saved in:
  15. 575
    Table_2_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.XLSX

    Table_2_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.XLSX by Emilie Faivre (5507582)

    Published 2018
    “…Interestingly, MSX-3 treatment led to a significant decrease of Aβ1-42 levels in the cortex of APP/PS1dE9 animals, while Aβ1-40 increased, thereby strongly affecting the Aβ1-42/Aβ1-40 ratio. …”
    Save to List
    Saved in:
  16. 576
    Table_1_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.XLSX

    Table_1_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.XLSX by Emilie Faivre (5507582)

    Published 2018
    “…Interestingly, MSX-3 treatment led to a significant decrease of Aβ1-42 levels in the cortex of APP/PS1dE9 animals, while Aβ1-40 increased, thereby strongly affecting the Aβ1-42/Aβ1-40 ratio. …”
    Save to List
    Saved in:
  17. 577
    Table_3_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.XLSX

    Table_3_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.XLSX by Emilie Faivre (5507582)

    Published 2018
    “…Interestingly, MSX-3 treatment led to a significant decrease of Aβ1-42 levels in the cortex of APP/PS1dE9 animals, while Aβ1-40 increased, thereby strongly affecting the Aβ1-42/Aβ1-40 ratio. …”
    Save to List
    Saved in:
  18. 578
    Table_4_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.XLSX

    Table_4_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.XLSX by Emilie Faivre (5507582)

    Published 2018
    “…Interestingly, MSX-3 treatment led to a significant decrease of Aβ1-42 levels in the cortex of APP/PS1dE9 animals, while Aβ1-40 increased, thereby strongly affecting the Aβ1-42/Aβ1-40 ratio. …”
    Save to List
    Saved in:
  19. 579
    Image_1_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.PDF

    Image_1_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.PDF by Emilie Faivre (5507582)

    Published 2018
    “…Interestingly, MSX-3 treatment led to a significant decrease of Aβ1-42 levels in the cortex of APP/PS1dE9 animals, while Aβ1-40 increased, thereby strongly affecting the Aβ1-42/Aβ1-40 ratio. …”
    Save to List
    Saved in:
  20. 580
    Fig 5 -

    Fig 5 - by Dennis Ochola (11626912)

    Published 2022
    Save to List
    Saved in:

Search Tools: